全文获取类型
收费全文 | 2308篇 |
免费 | 129篇 |
国内免费 | 15篇 |
专业分类
耳鼻咽喉 | 11篇 |
儿科学 | 94篇 |
妇产科学 | 33篇 |
基础医学 | 434篇 |
口腔科学 | 19篇 |
临床医学 | 297篇 |
内科学 | 486篇 |
皮肤病学 | 45篇 |
神经病学 | 220篇 |
特种医学 | 46篇 |
外科学 | 168篇 |
综合类 | 12篇 |
预防医学 | 208篇 |
眼科学 | 28篇 |
药学 | 190篇 |
中国医学 | 3篇 |
肿瘤学 | 158篇 |
出版年
2023年 | 18篇 |
2022年 | 20篇 |
2021年 | 46篇 |
2020年 | 33篇 |
2019年 | 45篇 |
2018年 | 63篇 |
2017年 | 45篇 |
2016年 | 54篇 |
2015年 | 57篇 |
2014年 | 87篇 |
2013年 | 117篇 |
2012年 | 181篇 |
2011年 | 201篇 |
2010年 | 104篇 |
2009年 | 97篇 |
2008年 | 160篇 |
2007年 | 153篇 |
2006年 | 144篇 |
2005年 | 130篇 |
2004年 | 110篇 |
2003年 | 114篇 |
2002年 | 91篇 |
2001年 | 31篇 |
2000年 | 28篇 |
1999年 | 33篇 |
1998年 | 26篇 |
1997年 | 14篇 |
1996年 | 19篇 |
1995年 | 14篇 |
1994年 | 11篇 |
1993年 | 11篇 |
1992年 | 9篇 |
1991年 | 11篇 |
1990年 | 12篇 |
1989年 | 17篇 |
1988年 | 9篇 |
1987年 | 13篇 |
1986年 | 9篇 |
1985年 | 12篇 |
1984年 | 6篇 |
1982年 | 6篇 |
1981年 | 6篇 |
1980年 | 7篇 |
1979年 | 11篇 |
1977年 | 7篇 |
1976年 | 6篇 |
1973年 | 4篇 |
1972年 | 4篇 |
1971年 | 5篇 |
1967年 | 5篇 |
排序方式: 共有2452条查询结果,搜索用时 15 毫秒
31.
32.
33.
34.
Bang CN Greve AM Boman K Egstrup K Gohlke-Baerwolf C Køber L Nienaber CA Ray S Rossebø AB Wachtell K 《American heart journal》2012,163(4):690-696
35.
36.
M Reincke E Fischer S Gerum K Merkle S Schulz A Pallauf M Quinkler G Hanslik K Lang S Hahner B Allolio C Meisinger R Holle F Beuschlein M Bidlingmaier S Endres;Participants of the German Conn's Registry-Else Kröner-Fresenius-Hyperaldosteronism Registry 《Hypertension》2012,60(3):618-624
In comparison with essential hypertension, primary aldosteronism (PA) is associated with an increased risk of cardiovascular morbidity. To date, no data on mortality have been published. We assessed mortality of patients treated for PA within the German Conn's registry and identified risk factors for adverse outcome in a case-control study. Patients with confirmed PA treated in 3 university centers in Germany since 1994 were included in the analysis. All of the patients were contacted in 2009 and 2010 to verify life status. Subjects from the population-based F3 survey of the Cooperative Health Research in the Region of Augsburg served as controls. Final analyses were based on 600 normotensive controls, 600 hypertensive controls, and 300 patients with PA. Kaplan-Meyer survival curves were calculated for both cohorts. Ten-year overall survival was 95% in normotensive controls, 90% in hypertensive controls, and 90% in patients with PA (P value not significant). In multivariate analysis, age (hazard ratio, 1.09 per year [95% CI, 1.03-1.14]), angina pectoris (hazard ratio, 3.6 [95% CI, 1.04-12.04]), and diabetes mellitus (hazard ratio, 2.55 [95% CI, 1.07-6.09]) were associated with an increase in all-cause mortality, whereas hypokalemia (hazard ratio, 0.41 per mmol/L [95% CI, 0.17-0.99]) was associated with reduced mortality. Cardiovascular mortality was the main cause of death in PA (50% versus 34% in hypertensive controls; P<0.05). These data indicate that cardiovascular mortality is increased in patients treated for PA, whereas all-cause mortality is not different from matched hypertensive controls. 相似文献
37.
Lutz Philipp Breitling Heiko Müller Christa Stegmaier Matthias Kliegel Hermann Brenner 《Experimental gerontology》2012
Objectives
Recent animal studies have suggested a key role for cellular prion protein (PrPc) in the pathological consequences of amyloid plaque formation, the hallmark of Alzheimer's disease. This epidemiological study investigated whether serum concentrations of PrPc are associated with cognitive functioning in humans.Design, Setting, Participants
Cross-sectional study of 1,322 participants from the elderly general population in Germany, aged 65 + years at baseline (2000–2002).Measurements
Cognitive functioning was assessed by the COGTEL phone interview 5 years after baseline. Serum PrPc was determined by a commercial immunoassay.Results
In multiple linear regression adjusted for important confounders, subjects in higher PrPc quintiles appeared to have lower cognitive functioning scores than those in the lowest PrPc quintile. Spline regression suggested pronounced non-linearity with an inverse association between PrPc and cognitive functioning levelling off beyond median PrPc. Cognitive subdomain-specific models produced somewhat heterogeneous results.Conclusion
The findings are suggestive of an independent association of PrPc with cognitive functioning in humans. Confirmatory and longitudinal studies are needed to elucidate the potential of PrPc for applications in early risk stratification for cognitive impairment. 相似文献38.
39.
Hunger M Schunk M Meisinger C Peters A Holle R 《Journal of diabetes and its complications》2012,26(5):413-418
ObjectivesObesity is known to be an important risk factor for type 2 diabetes and its related comorbid conditions; however, its specific impact on generic health-related quality of life (HRQL) is less clear. The objective of this study was to estimate the association between body mass index (BMI) and HRQL in individuals with type 2 diabetes.MethodsThe EQ-5D quality of life questionnaire was administered in a follow-up of 10,385 participants aged 33–94 of the population-based German MONICA/KORA surveys. 1033 participants with type 2 diabetes were identified by self-report combined with validated physician diagnoses. Semiparametric additive regression models were used to estimate the effect of BMI on EQ-5D health utilities adjusted for age, sex, education and comorbidities.ResultsBMI was significantly associated with EQ-5D health utilities even after adjustment for macro- and microvascular complications. The functional relationship between BMI and utilities was nonlinear, reflecting optimal health around 26 kg/m2 and significantly decreasing health utilities with increasing levels of overweight and obesity (? 0.09 points between BMI values 26 and 40). Among the diabetic complications, the history of a stroke (? 0.13) and neuropathy (? 0.10) were the strongest predictors of reduced health utility scores.ConclusionsBMI is strongly associated with health utilities in persons with type 2 diabetes. This suggests that lifestyle measures to reduce obesity can markedly improve patients' health-related quality of life and that the negative effect of potential weight gain should be taken into account when determining patient preferences for different type 2 diabetes treatment options. 相似文献
40.
Petersen HH Larsen MC Nielsen OW Kensing F Svendsen JH 《Journal of interventional cardiac electrophysiology》2012,34(3):317-324